Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2024-05-20 Annual Report
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Annual Report Classification · 95% confidence The document is a detailed communication from the Board of Directors of Ajooni Biotech Limited to the National Stock Exchange of India, dated May 20, 2024. It reports the outcome of the Board meeting held on the same day, including approval of audited financial results for the fiscal year ended March 31, 2024, along with the auditor's report and declaration of an unmodified opinion. The document contains comprehensive financial data such as standalone financial results for the quarter and year ended March 31, 2024, including income, expenses, profit, EPS, and a statement of assets and liabilities. It also discusses business developments and credit rating upgrades. The presence of full financial statements and detailed analysis for the fiscal year indicates this is the official annual financial report. It is not merely an announcement or a brief summary but contains substantive financial data and management commentary. Therefore, the document fits the definition of an Annual Report (10-K equivalent).
2024-05-20 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed communication from the Board of Directors of Ajooni Biotech Limited to the National Stock Exchange of India, dated May 20, 2024. It reports the outcome of the Board Meeting held on the same day, including approval of the audited financial results for the year ended March 31, 2024, along with the auditor's report and declaration of an unmodified opinion. The document contains comprehensive financial data such as standalone financial results for the quarter and year ended March 31, 2024, including income, expenses, profit, EPS, and a statement of assets and liabilities. The presence of full financial statements and detailed financial analysis for the fiscal year indicates this is the official annual financial report. The document is not merely an announcement or a brief summary but includes substantive financial data and analysis. Therefore, it fits the definition of an Annual Report (10-K equivalent).
2024-05-20 English
Press Release
Capital/Financing Update Classification · 85% confidence The document is a press release announcing a strategic partnership (MOU) between Ajooni Biotech Limited and UAMMCL to enhance cattle feed and moringa production. It includes business strategy, product information, and projected financial turnover for the next three years. There are no financial statements, regulatory disclosures, voting results, or management changes. The content focuses on a business update and partnership announcement rather than a formal financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is not a regulatory filing or certification. The best fitting category is Capital/Financing Update (CAP) as it relates to a strategic partnership expected to impact business growth and turnover, which is a form of capital/financing update through business development.
2024-05-17 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter from Ajooni Biotech Limited addressed to the National Stock Exchange of India Limited. It announces the signing of a Memorandum of Understanding (MOU) with another organization for business collaboration in the agriculture sector. The content focuses on a business partnership and operational plans rather than financial results, management changes, or regulatory filings. The document length is short (2007 characters) and does not contain financial data, audit information, or meeting materials. It is not a report, earnings release, or regulatory filing. The announcement of an MOU related to business collaboration fits best under a general regulatory announcement category since it does not match any other specific filing type such as M&A activity or capital update. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-05-17 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Ltd. regarding the filing of a Pre Issue Advertisement related to a proposed Rights Issue of Equity Shares by Ajooni Biotech Limited. It mentions the publication of the advertisement in newspapers and includes e-clippings of these advertisements. The document is short (3228 characters) and serves as an announcement or filing of the advertisement rather than the advertisement itself or a detailed financial report. There is no financial data, analysis, or detailed report content present. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2024-05-17 English
Board Meeting — AJOONI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the…
Regulatory Filings
2024-05-15 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.